Cancer Risk Assessment: Chemical Carcinogenesis, Hazard Evaluation, and Risk QuantificationISBN: 978-0-470-23822-6
Hardcover
864 pages
July 2010
|
CHING-HUNG HSU, PhD, DABT, is a Vice President at TaiGen
Biotechnology Co., Ltd. His professional experience includes
positions at Merck & Co., Inc., the U.S. Environmental
Protection Agency, and the California Environmental Protection
Agency. Dr. Hsu earned his BS from the National Taiwan University
and PhD from the Massachusetts Institute of Technology. He
completed his postdoctoral training at the University of California
at Berkeley. Dr. Hsu is board-certified in toxicology by the
American Board of Toxicology. He has published numerous
professional papers, book chapters, and technical reports. Dr. Hsu
serves on the Editorial Board of two international peer-reviewed
journals.
TODD STEDEFORD, PhD, JD, DABT, is a Toxicology Advisor and In-house Counsel for a multinational specialty chemical manufacturer. Previously, he was a human health toxicologist with the U.S. Environmental Protection Agency and an adjunct scientist with the Polish Academy of Sciences. Dr. Stedeford is board-certified in toxicology by the American Board of Toxicology and licensed to practice law in the District of Columbia and the State of Louisiana. He has authored over eighty publications including peer-reviewed scientific articles, government health assessments, legal articles, and scientific and legal book chapters.